NGN-401

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett SyndromeNCT05898620NGNEPhase 3Active not recruiting2029-12Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.